AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 291: G999-G1004, 2006; doi:10.1152/ajpgi.00187.2006
0193-1857/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldenring, J. R.
Right arrow Articles by Nomura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldenring, J. R.
Right arrow Articles by Nomura, S.

THEMES

Differentiation of the Gastric Mucosa III. Animal models of oxyntic atrophy and metaplasia

James R. Goldenring1,2 and Sachiyo Nomura3

1Nashville Department of Veterans Affairs Medical Center and 2Department of Surgery and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; and 3Department of Gastrointestinal Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

Submitted 2 May 2006 ; accepted in final form 15 May 2006

Gastric cancer in humans arises in the setting of oxyntic atrophy (parietal cell loss) and attendant hyperplastic and metaplastic lineage changes within the gastric mucosa. Helicobacter infection in mice and humans leads to spasmolytic polypeptide-expressing metaplasia (SPEM). In a number of mouse models, SPEM arises after oxyntic atrophy. In mice treated with the parietal cell toxic protonophore DMP-777, SPEM appears to arise from the transdifferentiation of chief cells. These results support the concept that intrinsic mucosal influences regulate and modulate the appearance of gastric metaplasia even in the absence of significant inflammation, whereas chronic inflammation is required for the further neoplastic transition.

gastric adenocarcinoma; spasmolytic polypeptide-expressing metaplasia; trefoil factor 2; intestinal metaplasia



Address for reprint requests and other correspondence: J. R. Goldenring, Vanderbilt Univ. School of Medicine, Dept. of Surgery, Epithelial Biology Program, 4160A MRB III, 465 21st Ave. S., Nashville, TN 37232-2733 (e-mail: jim.goldenring{at}vanderbilt.edu)




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. G. Fox, A. B. Rogers, M. T. Whary, Z. Ge, M. Ohtani, E. K. Jones, and T. C. Wang
Accelerated Progression of Gastritis to Dysplasia in the Pyloric Antrum of TFF2 / C57BL6 x Sv129 Helicobacter pylori-Infected Mice
Am. J. Pathol., November 1, 2007; 171(5): 1520 - 1528.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.